Hun-Mo Ryoo

479 total citations
30 papers, 300 citations indexed

About

Hun-Mo Ryoo is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Hun-Mo Ryoo has authored 30 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Hun-Mo Ryoo's work include Multiple Myeloma Research and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Hun-Mo Ryoo is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Hun-Mo Ryoo collaborates with scholars based in South Korea, United States and Nigeria. Hun-Mo Ryoo's co-authors include Sung Hwa Bae, Hanjong Ahn, Daniel Lee, Cheryn Song, Jun Hyuk Hong, Inkeun Park, Bumsik Hong, J.L. Lee, Dae Young Zang and Jung‐Hee Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Hun-Mo Ryoo

28 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hun-Mo Ryoo South Korea	10	112	106	102	98	53	30	300
Filomena Del Gaizo Italy	10	150 1.3×	95 0.9×	188 1.8×	134 1.4×	37 0.7×	20	423
Nadjat Mounedji France	10	97 0.9×	85 0.8×	98 1.0×	121 1.2×	57 1.1×	21	556
Clara Lam United States	8	51 0.5×	42 0.4×	127 1.2×	55 0.6×	35 0.7×	20	339
Kristín Bjarnadóttir Iceland	5	38 0.3×	100 0.9×	166 1.6×	54 0.6×	61 1.2×	8	335
Michelle Purdom United States	7	75 0.7×	107 1.0×	129 1.3×	29 0.3×	68 1.3×	13	293
Vittorio Fregoni Italy	11	52 0.5×	51 0.5×	157 1.5×	173 1.8×	35 0.7×	23	383
Fabrice Jardin France	9	59 0.5×	50 0.5×	81 0.8×	47 0.5×	110 2.1×	22	277
Helene F. S. Negaard Norway	10	49 0.4×	64 0.6×	58 0.6×	100 1.0×	22 0.4×	21	287
Won Jin Chang South Korea	12	110 1.0×	79 0.7×	177 1.7×	26 0.3×	56 1.1×	27	353
B. Steinke Germany	10	46 0.4×	35 0.3×	137 1.3×	86 0.9×	52 1.0×	28	276

Countries citing papers authored by Hun-Mo Ryoo

Since Specialization

Citations

This map shows the geographic impact of Hun-Mo Ryoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hun-Mo Ryoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hun-Mo Ryoo more than expected).

Fields of papers citing papers by Hun-Mo Ryoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hun-Mo Ryoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hun-Mo Ryoo. The network helps show where Hun-Mo Ryoo may publish in the future.

Co-authorship network of co-authors of Hun-Mo Ryoo

This figure shows the co-authorship network connecting the top 25 collaborators of Hun-Mo Ryoo. A scholar is included among the top collaborators of Hun-Mo Ryoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hun-Mo Ryoo. Hun-Mo Ryoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, A‐Jin, et al.. (2021). Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden. Blood Research. 56(4). 259–265. 14 indexed citations

Jeon, Taewon, Min Ji Ko, Ilseon Hwang, et al.. (2017). Abstract 3113: Knockdown of cell division cycle-associated 8 (CDCA8) suppresses hepatocellular carcinoma growth via the upregulation of tumor suppressor ATF3. Cancer Research. 77(13_Supplement). 3113–3113. 4 indexed citations

Lim, Sung-Nam, Hyesook Han, Sang‐Cheol Lee, et al.. (2015). A Satisfaction Survey on Cancer Pain Management Using a Self-Reporting Pain Assessment Tool. Journal of Palliative Medicine. 18(3). 225–231. 13 indexed citations

Lee, J.L., Inkeun Park, Daniel Lee, et al.. (2015). RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. Annals of Oncology. 26(11). 2300–2305. 86 indexed citations

Lee, Je‐Hwan, Hawk Kim, Young‐Don Joo, et al.. (2015). A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia. Blood. 126(23). 2535–2535. 2 indexed citations

Kim, Hawk, Je‐Hwan Lee, Young‐Don Joo, et al.. (2014). Prospective, Multicenter, Phase II Study on Reducing the Dosage of Idarubicin and FLAG for Patients Younger than 65 Years with Resistant Acute Myeloid Leukemia: A Comparison with a Higher Dosage Trial. Acta Haematologica. 132(1). 87–96. 5 indexed citations

Kim, Hawk, Won-Sik Lee, Kyoo‐Hyung Lee, et al.. (2014). Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia. Annals of Hematology. 94(5). 739–746. 15 indexed citations

Cho, Chang‐Ho, et al.. (2013). Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.. PubMed. 6(8). 1643–51. 7 indexed citations

Ryoo, Hun-Mo. (2011). Management of Pulmonary Metastasis. The Korean Journal of Internal Medicine. 81(3). 289–299.

10.

Oh, Do‐Youn, Keun Wook Lee, Kyunghee Lee, et al.. (2011). A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. Investigational New Drugs. 30(3). 1164–1174. 16 indexed citations

11.

Bae, Sung Hwa, et al.. (2011). Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation. Cancer Research and Treatment. 43(4). 255–259. 15 indexed citations

12.

Lee, Sung Sook, Cheolwon Suh, Bong-Seog Kim, et al.. (2010). Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety. Annals of Hematology. 89(9). 905–912. 16 indexed citations

13.

Kim, Hawk, Jae-Hoo Park, Je‐Hwan Lee, et al.. (2010). Prospective Randomized Comparison of Cyclophosphamide Versus Cyclophosphamide Plus Fludarabine In Addition to Anti-Thymocyte Globulin for the Conditioning Therapy In Allogeneic Hematopoietic Cell Transplantation for Bone Marrow Failure Syndrome. Blood. 116(21). 34–34. 2 indexed citations

14.

Bae, Sung Hwa, Hun-Mo Ryoo, Won Sik Lee, et al.. (2010). High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial.. Blood. 116(21). 3687–3687. 30 indexed citations

15.

Kang, Byung Woog, Joon Ho Moon, Yee Soo Chae, et al.. (2010). Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors. Annals of Hematology. 89(8). 813–820. 1 indexed citations

16.

Koh, Young‐Il, Jae Hoon Lee, Hwi‐Joong Yoon, et al.. (2009). Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide. Annals of Hematology. 89(2). 201–206. 26 indexed citations

17.

Lee, Sung Sook, Cheolwon Suh, Bong-Seog Kim, et al.. (2007). Bortezomib, Doxorubicin and Dexamethasone (PAD) Combination Therapy Followed by Thalidomide and Dexamethasone (TD) as a Salvage Treatment for Relapsed Multiple Myeloma (MM): Preliminary Analysis of Efficacy and Safety.. Blood. 110(11). 2731–2731. 3 indexed citations

18.

Kim, Kyung‐Chan, Soyeon Kim, Hun-Mo Ryoo, et al.. (2005). Efficacy of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. The Korean Journal of Internal Medicine. 69(4). 379–386. 1 indexed citations

19.

Kim, Soyeon, Jiyoung Kim, Hun-Mo Ryoo, et al.. (2004). Oxaliplatin and UFT, leucovorin combination chemotherapy in patients with advanced colorectal cancer.. The Korean Journal of Internal Medicine. 67(1). 58–64. 1 indexed citations

20.

Kim, Min Kyoung, et al.. (2004). The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-Fluorouracil Based Chemotherapy. Cancer Research and Treatment. 36(6). 367–367. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact